Elvira Infante

Dr. Elvira Infante

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2015 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
VMValentina Marchesin
Valentina Marchesin
ACAntonio Castro-Castro
Antonio Castro-Castro
CLCatalina Lodillinsky
Catalina Lodillinsky
ACAlessia Castagnino
Alessia Castagnino
JCJoanna Cyrta
Joanna Cyrta
PCPhilippe Chavrier
Philippe Chavrier
Invasion of cancer cells into collagen-rich extracellular matrix requires membrane-tethered membrane type 1–matrix metalloproteinase (MT1-MMP) as the key protease for collagen breakdown. Understanding how MT1-MMP is delivered to the surface of tumor cells is essential for cancer cell biology. In this study, we identify ARF6 together with c-Jun NH2-terminal kinase–interacting protein 3 and 4 (JIP3 and JIP4) effectors as critical regulators of this process. Silencing ARF6 or JIP3/JIP4 in breast tumor cells results in MT1-MMP endosome mispositioning and reduces MT1-MMP exocytosis and tumor cell invasion. JIPs are recruited by Wiskott-Aldrich syndrome protein and scar homologue (WASH) on MT1-MMP endosomes on which they recruit dynein–dynactin and kinesin-1. The interaction of plasma membrane ARF6 with endosomal JIPs coordinates dynactin–dynein and kinesin-1 activity in a tug-of-war mechanism, leading to MT1-MMP endosome tubulation and exocytosis. In addition, we find that ARF6, MT1-MMP, and kinesin-1 are up-regulated in high-grade triple-negative breast cancers. These data identify a critical ARF6–JIP–MT1-MMP–dynein–dynactin–kinesin-1 axis promoting an invasive phenotype of breast cancer cells.

22 June 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
EIElvira Infante
Elvira Infante
ACAlessia Castagnino
Alessia Castagnino
RFRobin Ferrari
Robin Ferrari
PMPedro Monteiro
Pedro Monteiro
SASonia Agüera-GonzálEz
Sonia Agüera-GonzálEz
PCPhilippe Chavrier
Philippe Chavrier
Cancer cells’ ability to migrate through constricting pores in the tissue matrix is limited by nuclear stiffness. MT1-MMP contributes to metastasis by widening matrix pores, facilitating confined migration. Here, we show that modulation of matrix pore size or of lamin A expression known to modulate nuclear stiffness directly impinges on levels of MT1-MMP-mediated pericellular collagenolysis by cancer cells. A component of this adaptive response is the centrosome-centered distribution of MT1-MMP intracellular storage compartments ahead of the nucleus. We further show that this response, including invadopodia formation in association with confining matrix fibrils, requires an intact connection between the nucleus and the centrosome via the linker of nucleoskeleton and cytoskeleton (LINC) complex protein nesprin-2 and dynein adaptor Lis1. Our results uncover a digest-on-demand strategy for nuclear translocation through constricted spaces whereby confined migration triggers polarization of MT1-MMP storage compartments and matrix proteolysis in front of the nucleus depending on nucleus-microtubule linkage.

20 April 2015 in Oncogene
Verified
Journal Article
Closed access
CLC Lodillinsky
C Lodillinsky
EIElvira Infante
Elvira Infante
AGA Guichard
A Guichard
RCR Chaligné
R Chaligné
LFL Fuhrmann
L Fuhrmann
PCP Chavrier
P Chavrier

14 March 2014 in Nature Communications
Verified
Journal Article
Open access
HFHongmei Fu
Hongmei Fu
MKMadhav Kishore
Madhav Kishore
BGBeartice Gittens
Beartice Gittens
GWGuosu Wang
Guosu Wang
DCDavid Coe
David Coe
FMFederica M. Marelli-Berg
Federica M. Marelli-Berg
Localization of CD4(+)CD25(+)Foxp3(+) regulatory T (Treg) cells to lymphoid and non-lymphoid tissue is instrumental for the effective control of immune responses. Compared with conventional T cells, Treg cells constitute a minute fraction of the T-cell repertoire. Despite this numeric disadvantage, Tregs efficiently migrate to sites of immune responses reaching an optimal number for the regulation of T effector (Teff) cells. The array and levels of adhesion and chemokine receptor expression by Tregs do not explain their powerful migratory capacity. Here we show that recognition of self-antigens expressed by endothelial cells in target tissue is instrumental for efficient Treg recruitment in vivo. This event relies upon IFN-γ-mediated induction of MHC-class-II molecule expression by the endothelium and requires optimal PI3K p110δ activation by the T-cell receptor. We also show that, once in the tissue, Tregs inhibit Teff recruitment, further enabling a Teff:Treg ratio optimal for regulation.

25 June 2013 in Journal of Leukocyte Biology
Verified
Journal Article
Closed access
PDF file
PFPatricia Favaro
Patricia Favaro
FTFabiola Traina
Fabiola Traina
JMJoão Agostinho Machado-Neto
João Agostinho Machado-Neto
MLMariana Lazarini
Mariana Lazarini
MLMatheus Rodrigues Lopes
Matheus Rodrigues Lopes
SSSara Teresinha Olalla Saad
Sara Teresinha Olalla Saad
The human FMNL1 is expressed predominantly in hematopoietic cells and has been described previously as overexpressed in hematopoietic malignancies. However, it is not known whether FMNL1 contributes to leukemogenesis. Here, we investigate the FMNL1 function using two different human leukemia models: Namalwa and K562 cell lines. FMNL1 depletion reduced cell proliferation and colony formation in both leukemic cell types, as well as a decrease in the tumor growth of FMNL1-depleted Namalwa cell xenografts. In addition, there was a decrease in migration and in TEM in FMNL1-depleted Namalwa cells. FMNL1 endogenously associates with Rac1, and FMNL1 silencing resulted in an increased Rac1 activity. The reduced migration observed in FMNL1-depleted cells was restored by inhibiting Rac activity. Our results indicate that FMNL1 stimulates leukemia cell proliferation as well as migration. This suggests that FMNL1 contributes to leukemogenesis and could act in part through Rac1 regulation.

20 February 2012 in Oncogene
Verified
Journal Article
Open access
PDF file
PBP J Bhavsar
P J Bhavsar
EIElvira Infante
Elvira Infante
AKA Khwaja
A Khwaja
ARA J Ridley
A J Ridley
NOTCH1 is frequently mutated in T-cell acute lymphoblastic leukaemia (T-ALL), and can stimulate T-ALL cell survival and proliferation. Here we explore the hypothesis that Notch1 also alters T-ALL cell migration. Rho GTPases are well known to regulate cell adhesion and migration. We have analysed the expression levels of Rho GTPases in primary T-ALL samples compared with normal T cells by quantitative PCR. We found that 5 of the 20 human Rho genes are highly and consistently upregulated in T-ALL, and 3 further Rho genes are expressed in T-ALL but not detectable in normal T cells. Of these, RHOU expression is highly correlated with the expression of the Notch1 target DELTEX-1. Inhibition of Notch1 signalling with a γ-secretase inhibitor (GSI) or Notch1 RNA interference reduced RhoU expression in T-ALL cells, whereas constitutively active Notch1 increased RhoU expression. In addition, Notch1 or RhoU depletion, or GSI treatment, inhibits T-ALL cell adhesion, migration and chemotaxis. These results indicate that NOTCH1 mutation stimulates T-ALL cell migration through RhoU upregulation that could contribute to the leukaemia cell dissemination.